Statin Safety Report Due Out At Year-End, National Lipid Assoc. Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Preliminary results of the National Lipid Association statin safety task force's retrospective study of claims database shows Crestor's incidence of renal events and rhabdomyolysis fall in the middle of the statin class.